Parkinson’s disease is a neurodegenerative disease that causes nerve cells in the brain to die leading to impaired movement, ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...

In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday ...

Ozzy Osbourne will come out of touring retirement and reunite with the full Black Sabbath lineup for the first time in 20 ...

The Parkinson’s Foundation estimates that 15,000 people here in Wisconsin have Parkinson’s disease, and that number is only ...

The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.

Danish film director Lars von Trier has been admitted to a care facility for Parkinson’s disease, his producer said Wednesday ...

By creating a new metric, researchers envision the possibility of diagnostic and treatment advances for the disease, which is estimated to affect about 4 million people worldwide.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...